Nabriva Therapeutics (NASDAQ:NBRV) Receives New Coverage from Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Nabriva Therapeutics (NASDAQ:NBRV – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock. Nabriva Therapeutics Price Performance Shares of Nabriva Therapeutics stock opened at $0.00 on Wednesday. The firm has a market capitalization of $6,403.00, […]
4 Oct 05:31 · The Cerbat Gem